Clinical Trial Update: Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B [Phase 3]

View source ↗

Summary

Phase 3 trial comparing immunogenicity and safety of DTP-HB-Hib (Bio Farma) with Pentabio vaccine when primed with recombinant Hepatitis B; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunogenicity
• Safety

Drugs mentioned

• DTP/HB/Hib (Bio Farma)
• Pentabio (pentavalent vaccine (DTP-HepB-Hib))

Snippet

Sponsor: PT Bio Farma | Conditions: Immunogenicity, Safety | Phase 3 | Status: COMPLETED